[go: up one dir, main page]

Bray, 2017 - Google Patents

The Intellectual Disability Gene UPF3B Promotes the Downregulation of Key Neural Transcripts and the Survival of Pluripotent Cells

Bray, 2017

Document ID
4552724606960439812
Author
Bray W
Publication year

External Links

Snippet

Mutations in the protein UPF3B, a member of the Nonsense-Mediated RNA Decay pathway, have been shown to cause a form of X-linked intellectual disability with a highly variable clinical presentation (UPF3B-XLID) that can include autism spectrum disorders, early onset …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides

Similar Documents

Publication Publication Date Title
US20240229078A1 (en) Materials and methods for treatment of glycogen storage disease type 1a
JP2020534826A (en) Modification of specificity of non-coding RNA molecules for silencing gene expression in eukaryotic cells
JP2022545461A (en) Compositions and methods for identifying regulators of cell type fate specification
Han et al. NEIL1 and NEIL2 DNA glycosylases protect neural crest development against mitochondrial oxidative stress
EP2971056A2 (en) Cellular discovery platform for neurodegenerative diseases
CN107603976A (en) Methods and compositions for RNA-directed target DNA modification and for RNA-directed transcriptional regulation
Rigal et al. Artificially stimulating retrotransposon activity increases mortality and accelerates a subset of aging phenotypes in Drosophila
WO2018020323A2 (en) Materials and methods for treatment of fatty acid disorders
US11459570B2 (en) Transgenic mouse expressing amyloid precursor protein that has olfactory neuron degeneration
Bray The Intellectual Disability Gene UPF3B Promotes the Downregulation of Key Neural Transcripts and the Survival of Pluripotent Cells
Sirois Generation of Isogenic Human Pluripotent Stem Cell-Derived Neurons to Establish a Molecular Angelman Syndrome Phenotype and to Study the UBE3A Protein Isoforms
Conti DDI1/2 and RTF2-Dependent Regulation of RNASE H2 at the Replisome Ensures Genome Stability
Pappada DEVELOPMENT OF THERAPEUTIC STRATEGIES FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIAS TYPE 1 AND 2 (SCA1 AND SCA2)
Schweingruber et al. Single-cell RNA sequencing across isogenic FUS and TARDBP ALS lines reveals a shared early mitochondrial dysfunction unique to motor neurons
Brazane Functions of the ribose methyltransferase FTSJ1 in regulation of gene expression and neural development
Gnocchi Understanding the impact of replication stress on the expression of early genes in mouse embryonic stem cells
Cernigoj Investigating the immediate consequences of normal and mutant HTT loss in HD-hESC through the dTAG system.
Preza Stem cell models of C9orf72-linked Frontotemporal Dementia
Sanders Studying human neuropsychiatric disease in DLG2 deficient neurons
Song Three-dimensional epigenomic characterization reveals insights into gene regulation and disease in the human brain
Shy Genome Editing and Differentiation of Embryonic Stem Cells
Cheung Deciphering X-chromosome inactivation and the role of MECP2e1 in Rett Syndrome patient induced pluripotent stem cells
CN117940560A (en) Novel small RNA programmable endonuclease system with improved PAM specificity and its uses
Priami THE ROLE OF THE P53/P66SHC PATHWAY IN DEVELOPMENT AND AGING: DANIO RERIO (ZEBRAFISH) AND NOTHOBRANCHIUS AS MODEL ORGANISMS
Lorente Pons Investigation of oligodendroglial pathology in amyotrophic lateral sclerosis